エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/26 | 8,355 | 8,385 | 8,264 | 8,281 | -35 | -0.4% | 938,400 |
| 2023/01/25 | 8,210 | 8,399 | 8,209 | 8,316 | +107 | +1.3% | 1,824,800 |
| 2023/01/24 | 8,267 | 8,280 | 8,091 | 8,209 | -68 | -0.8% | 2,305,700 |
| 2023/01/23 | 8,331 | 8,429 | 8,256 | 8,277 | -117 | -1.4% | 1,716,100 |
| 2023/01/20 | 8,316 | 8,483 | 8,203 | 8,394 | +228 | +2.8% | 3,383,400 |
| 2023/01/19 | 8,250 | 8,258 | 8,134 | 8,166 | -178 | -2.1% | 1,384,000 |
| 2023/01/18 | 8,182 | 8,367 | 8,171 | 8,344 | +191 | +2.3% | 2,335,900 |
| 2023/01/17 | 8,295 | 8,300 | 8,081 | 8,153 | -117 | -1.4% | 2,359,100 |
| 2023/01/16 | 8,100 | 8,327 | 8,065 | 8,270 | +167 | +2.1% | 3,637,600 |
| 2023/01/13 | 8,000 | 8,213 | 7,972 | 8,103 | -9 | -0.1% | 3,154,900 |
| 2023/01/12 | 8,270 | 8,292 | 7,990 | 8,112 | -217 | -2.6% | 4,234,100 |
| 2023/01/11 | 8,578 | 8,686 | 8,329 | 8,329 | -212 | -2.5% | 4,835,600 |
| 2023/01/10 | 8,896 | 8,896 | 8,375 | 8,541 | +394 | +4.8% | 10,880,100 |
| 2023/01/06 | 8,000 | 8,253 | 7,972 | 8,147 | +26 | +0.3% | 2,547,200 |
| 2023/01/05 | 8,213 | 8,247 | 7,935 | 8,121 | -60 | -0.7% | 2,802,900 |
| 2023/01/04 | 8,554 | 8,626 | 8,154 | 8,181 | -523 | -6% | 2,427,000 |
| 2022/12/30 | 8,702 | 8,760 | 8,632 | 8,704 | -3 | ±0% | 1,264,700 |
| 2022/12/29 | 8,617 | 8,721 | 8,506 | 8,707 | +100 | +1.2% | 1,127,500 |
| 2022/12/28 | 8,580 | 8,673 | 8,513 | 8,607 | -33 | -0.4% | 1,208,100 |
| 2022/12/27 | 8,712 | 8,828 | 8,636 | 8,640 | -26 | -0.3% | 1,067,900 |
| 2022/12/26 | 8,680 | 8,722 | 8,622 | 8,666 | -8 | -0.1% | 1,102,100 |
| 2022/12/23 | 8,885 | 8,890 | 8,411 | 8,674 | -326 | -3.6% | 4,440,900 |
| 2022/12/22 | 9,061 | 9,088 | 8,945 | 9,000 | -10 | -0.1% | 1,173,300 |
| 2022/12/21 | 9,050 | 9,147 | 8,956 | 9,010 | -28 | -0.3% | 1,520,700 |
| 2022/12/20 | 9,373 | 9,387 | 9,002 | 9,038 | -354 | -3.8% | 2,349,400 |
| 2022/12/19 | 9,427 | 9,453 | 9,309 | 9,392 | -108 | -1.1% | 1,246,400 |
| 2022/12/16 | 9,468 | 9,500 | 9,373 | 9,500 | -2 | ±0% | 2,234,300 |
| 2022/12/15 | 9,590 | 9,656 | 9,502 | 9,502 | -111 | -1.2% | 1,031,100 |
| 2022/12/14 | 9,524 | 9,661 | 9,515 | 9,613 | +111 | +1.2% | 1,361,000 |
| 2022/12/13 | 9,525 | 9,574 | 9,443 | 9,502 | -78 | -0.8% | 1,281,300 |
| 2022/12/12 | 9,460 | 9,587 | 9,435 | 9,580 | +37 | +0.4% | 1,452,500 |
| 2022/12/09 | 9,479 | 9,677 | 9,474 | 9,543 | -86 | -0.9% | 2,071,000 |
| 2022/12/08 | 9,724 | 9,762 | 9,547 | 9,629 | -112 | -1.1% | 1,850,600 |
| 2022/12/07 | 9,568 | 9,834 | 9,561 | 9,741 | +18 | +0.2% | 2,147,700 |
| 2022/12/06 | 9,850 | 9,950 | 9,691 | 9,723 | -327 | -3.3% | 3,998,000 |
| 2022/12/05 | 9,623 | 10,050 | 9,476 | 10,050 | +495 | +5.2% | 6,275,900 |
| 2022/12/02 | 9,634 | 9,674 | 9,482 | 9,555 | -220 | -2.3% | 4,426,200 |
| 2022/12/01 | 9,530 | 10,050 | 9,495 | 9,775 | +443 | +4.7% | 11,389,300 |
| 2022/11/30 | 9,124 | 9,481 | 8,807 | 9,332 | +344 | +3.8% | 9,578,900 |
| 2022/11/29 | 9,134 | 9,135 | 8,473 | 8,988 | -596 | -6.2% | 9,064,400 |
| 2022/11/28 | 9,468 | 9,658 | 9,456 | 9,584 | +116 | +1.2% | 2,085,900 |
| 2022/11/25 | 9,492 | 9,514 | 9,343 | 9,468 | -12 | -0.1% | 1,639,300 |
| 2022/11/24 | 9,324 | 9,557 | 9,300 | 9,480 | +270 | +2.9% | 2,762,900 |
| 2022/11/22 | 8,951 | 9,218 | 8,951 | 9,210 | +267 | +3% | 1,973,400 |
| 2022/11/21 | 8,911 | 9,022 | 8,863 | 8,943 | -5 | -0.1% | 1,094,900 |
| 2022/11/18 | 8,658 | 8,948 | 8,605 | 8,948 | +349 | +4.1% | 1,623,200 |
| 2022/11/17 | 8,531 | 8,627 | 8,515 | 8,599 | +78 | +0.9% | 879,500 |
| 2022/11/16 | 8,750 | 8,756 | 8,521 | 8,521 | -232 | -2.7% | 1,403,600 |
| 2022/11/15 | 8,773 | 8,938 | 8,721 | 8,753 | +465 | +5.6% | 2,601,900 |
| 2022/11/14 | 8,320 | 8,433 | 8,276 | 8,288 | -99 | -1.2% | 1,381,700 |
451～
500
件表示中 / 3587件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 465,300円 | +1.7% | -2.9% | 3.44% | 30.53倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 157,200円 | +12.2% | +180.3% | 4.71% | 56.28倍 | 1.84倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 212,400円 | +5.7% | +3.9% | 2.70% | 10.57倍 | 1.40倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 250,200円 | +11.3% | -5.4% | 2.32% | 19.26倍 | 1.52倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 171,700円 | -3.5% | -50.2% | 4.66% | 13.91倍 | 1.03倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
